Corrigendum to "Immune mechanisms and novel therapies for idiopathic pulmonary fibrosis" [Pharmaceut. Sci. Adv. 2 (2024), 100030].

Gao D, Gao W, Zhai Z, Zhu W

Open source

DOI
10.1016/j.pscia.2026.100144
Published
2026 Dec
Container
Pharmaceutical science advances
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.pscia.2026.100144,
  title = {Corrigendum to "Immune mechanisms and novel therapies for idiopathic pulmonary fibrosis" [Pharmaceut. Sci. Adv. 2 (2024), 100030].},
  author = {Gao D and Gao W and Zhai Z and Zhu W},
  year = {2026},
  journal = {Pharmaceutical science advances},
  doi = {10.1016/j.pscia.2026.100144},
  url = {https://doi.org/10.1016/j.pscia.2026.100144}
}

RIS

TY  - JOUR
TI  - Corrigendum to "Immune mechanisms and novel therapies for idiopathic pulmonary fibrosis" [Pharmaceut. Sci. Adv. 2 (2024), 100030].
AU  - Gao D
AU  - Gao W
AU  - Zhai Z
AU  - Zhu W
PY  - 2026
JO  - Pharmaceutical science advances
DO  - 10.1016/j.pscia.2026.100144
UR  - https://doi.org/10.1016/j.pscia.2026.100144
ER  - 

APA

D, G., W, G., Z, Z., & W, Z. (2026). Corrigendum to "Immune mechanisms and novel therapies for idiopathic pulmonary fibrosis" [Pharmaceut. Sci. Adv. 2 (2024), 100030].. Pharmaceutical science advances. https://doi.org/10.1016/j.pscia.2026.100144

Source records